首页> 外文期刊>Journal of Clinical Oncology >Mutations of hMLH1 and hMSH2 in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with microsatellite instability and abnormalities of mismatch repair protein expression.
【24h】

Mutations of hMLH1 and hMSH2 in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with microsatellite instability and abnormalities of mismatch repair protein expression.

机译:怀疑是遗传性非息肉病性大肠癌患者的hMLH1和hMSH2突变:与微卫星不稳定性和错配修复蛋白表达异常相关。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: The relationship between germ-line mutations of hMSH2 and hMLH1, microsatellite instability (MSI), and loss of DNA mismatch repair (MMR) gene expression were studied to formulate an effective selection protocol for patients with suspected hereditary nonpolyposis colorectal cancer who should be offered genetic testing. PATIENTS AND METHODS: Patients eligible for germ-line analysis of hMLH1 and hMSH2 were selected. Tumor specimens were obtained to assess MSI and loss of MMR gene expression. RESULTS: Among 37 patients who participated in the study, two hMSH2 and two hMLH1 missense mutations (11%) were detected, none of which was found in a panel of 60 healthy volunteers. High MSI was found in five tumors (19%) and low MSI in 10 tumors (39%); 12 tumors (46%) were microsatellite stable. Four tumors demonstrated loss of hMLH1, and three tumors demonstrated loss of hMSH2 protein expression. CONCLUSION: No relationship was found between MMR gene mutations and MSI; low or no MSI was found in the four patients with germ-line mutations, and none of the five patients with high MSI demonstrated abnormalities of MMR genes. On the contrary, loss of hMLH1 or hMSH2 expression was found in the tumors from three of the four patients demonstrating germ-line mutations. These data suggest that germ-line mutations of the MMR gene can occur in people with MSI-negative tumors. Sensitive clinical criteria and the study of MMR gene expression may be useful to identify this subset of patients.
机译:目的:研究hMSH2和hMLH1的种系突变,微卫星不稳定性(MSI)和DNA错配修复(MMR)基因表达缺失之间的关系,为疑似遗传性非息肉性结直肠癌的患者制定有效的选择方案。提供了基因测试。患者和方法:选择符合hMLH1和hMSH2种系分析条件的患者。获得肿瘤样品以评估MSI和MMR基因表达的损失。结果:在参与该研究的37名患者中,检测到两个hMSH2和两个hMLH1错义突变(11%),在60名健康志愿者中均未发现。在5个肿瘤中发现MSI高(19%),在10个肿瘤中发现MSI低(39%); 12个肿瘤(46%)是微卫星稳定的。四个肿瘤表现出hMLH1的缺失,三个肿瘤表现出hMSH2蛋白表达的缺失。结论:MMR基因突变与MSI无相关性。在具有种系突变的4例患者中发现MSI低或没有MSI,而在5例具有高MSI的患者中均未显示MMR基因异常。相反,在四名表现出种系突变的患者中,有三名在肿瘤中发现了hMLH1或hMSH2表达的丧失。这些数据表明,MMR基因的种系突变可能发生在MSI阴性肿瘤患者中。敏感的临床标准和MMR基因表达的研究可能有助于识别患者的这一子集。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号